Kolibri (KGEI) 2025 Earnings Outlook: Q4 Deep Dive
As Kolibri wraps its Q4 2025 results, investors seek clarity on growth, margins, and cash flow. This article translat...
Which Is Better Glide Path Or Passive For Retirement
Explore how glide paths and passive retirement options work, including risk and cost differences. This intro helps you compare pros and cons before choosing a strategy.
26,696 articles
JPMorgan Chase Eyeing Interest Growth: 7% NII Target
JPMorgan Chase has set a bold 7% net interest income growth goal for 2026. This article explains why the target could...
Why Lucid Stock Bounced Back Today: A Practical Guide for Investors
An unusual trading day put Lucid Group in the spotlight after rumors swirled about bankruptcy or going private. Learn...
Citi Flags Agilent Technologies, Trims Icon Target
Citi issued a life sciences sector note that elevates Agilent Technologies while reducing Icon PLC’s target, signalin...
XRP Futures Surge Makes Waves as Price Stays Sub-$1.40
XRP's price stays below $1.40 even as CME-listed futures surpass $63 billion in notional in their first year. Traders...
Meet Medtech Stock Wall: A 12-Month Growth Outlook for 2026
A struggling medtech name is sparking renewed optimism from analysts. This guide breaks down why a 65% upside is poss...
SpaceX Stock: Dip? Is It a Buy for the Bold Investor?
SpaceX remains a private giant with sky-high growth prospects. If spacex stock: dip? ever becomes a reality, investor...
Oracle's AI-Fueled Growth Silences Doubters — for Now
Oracle has faced skepticism around AI spending and cloud growth. This article digs into how Oracle's AI-Fueled Growth...
This Stock Cheap Right: Why I'm Buying AI Shares Now
Value seekers are spotting a window: a well-known tech name trading at a discount as AI momentum roars. Here’s how to...
Figma Stock Poised Upside: Markets Rally Amid AI Push
Figma is showing early signs of revival after a volatile debut, with improving revenue growth and expanding enterpris...
Cathie Wood's $362 Million CRISPR Bet: Hidden Catalyst
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
HeartBeam (Beat) 2025 Earnings: What Investors Need
HeartBeam heads into 2025 earnings with a mix of potential breakthroughs and headwinds. This guide explains what the ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status